Medicare Enrolled
Dr. Ahmad Jingo, MD
Internal Medicine · Decatur, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jingo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jingo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jingo
Dr. Ahmad Jingo is an internal medicine specialist in Decatur, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jingo performed 1,178 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jingo received a total of $6,011 from 42 pharmaceutical and/or device companies across 367 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jingo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 30% volume in GA
$6,011 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,178
Medicare services
Top 30% in GA for internal medicine
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
314 | $61 | $105 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
198 | $31 | $58 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
112 | $38 | $71 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
78 | $0 | $45 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
76 | $38 | $73 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
75 | $4 | $25 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
64 | $10 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
35 | $8 | $30 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
29 | $15 | $28 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
27 | $44 | $294 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
25 | $12 | $150 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
25 | $70 | $376 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $37 | $82 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
23 | $63 | $300 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
20 | $127 | $193 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
19 | $144 | $345 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
18 | $61 | $150 |
| Urinalysis for bacteria A urine test to check for the presence of bacteria. This procedure analyzes a urine sample to detect bacterial growth. |
15 | $29 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.6% high complexity
8.6% medium
89.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,011
Total received (2018-2024)
Avg $859/year across 7 years
Top 13% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
367
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$695
2023
$1,067
2022
$1,208
2021
$1,124
2020
$583
2019
$802
2018
$532
Payments by company (2024)
ABBVIE INC.
$142
AstraZeneca Pharmaceuticals LP
$82
Novo Nordisk Inc
$68
Lilly USA, LLC
$63
PFIZER INC.
$58
Inspire Medical Systems, Inc.
$50
Otsuka America Pharmaceutical, Inc.
$38
Collegium Pharmaceutical, Inc.
$37
Lundbeck LLC
$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$24
Echosens North America, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$20
Phathom Pharmaceuticals, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Astellas Pharma US Inc
$18
Top 3 companies account for 42.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,229
GlaxoSmithKline, LLC.
$567
ABBVIE INC.
$500
AbbVie Inc.
$452
Collegium Pharmaceutical, Inc.
$384
Novo Nordisk Inc
$374
Boehringer Ingelheim Pharmaceuticals, Inc.
$267
Lilly USA, LLC
$218
SANOFI-AVENTIS U.S. LLC
$197
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$145
Astellas Pharma US Inc
$128
Sunovion Pharmaceuticals Inc.
$117
Novartis Pharmaceuticals Corporation
$117
Otsuka America Pharmaceutical, Inc.
$108
PFIZER INC.
$104
Supernus Pharmaceuticals, Inc.
$91
Amgen Inc.
$88
Abbott Laboratories
$81
Lundbeck LLC
$76
Janssen Pharmaceuticals, Inc
$76
Hikma Pharmaceuticals USA
$61
Allergan Inc.
$59
Merck Sharp & Dohme Corporation
$57
Bayer HealthCare Pharmaceuticals Inc.
$52
Inspire Medical Systems, Inc.
$50
Allergan, Inc.
$41
Endo Pharmaceuticals Inc.
$39
Vertical Pharmaceuticals, LLC
$39
Sumitomo Pharma America, Inc.
$37
Xeris Pharmaceuticals, Inc.
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$24
Masimo Corporation
$23
IMPEL PHARMACEUTICALS INC.
$23
Echosens North America, Inc.
$22
Shield Therapeutics Inc
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Phathom Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$20
Kowa Pharmaceuticals America, Inc.
$18
Eisai Inc.
$18
Carolina Liquid Chemistries Corp
$15
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · BASAGLAR · BELBUCA · BREZTRI · BYSTOLIC · Belbuca · CAPLYTA · CREON · Dayvigo · ELIQUIS · ELYXYB - celecoxib · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · GEMTESA · GVOKE HYPOPEN · INSPIRE · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · LORZONE · Livalo · METHYLPHENIDATE 72 · MOUNJARO · MOVANTIK · MYRBETRIQ · Mitigare · NASCOBAL · NURTEC ODT · OXTELLAR XR · Ozempic · PREVNAR - 13 · Patient SafetyNet System · Prolia · QULIPTA · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trudhesa · UBRELVY · VOQUEZNA · VRAYLAR · Veozah · XARELTO · XIFAXAN · XTAMPZA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,112
County median income
$77,683
Nearest hospital to ZIP centroid (approximate)
GEORGIA REGIONAL HOSPITAL ATLANTA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jingo is a clinical cardiology specialist, with above-average Medicare volume (top 30% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jingo experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Jingo performed 314 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jingo receive payments from pharmaceutical companies?
Yes. Dr. Jingo received a total of $6,011 from 42 companies across 367 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jingo's costs compare to other internal medicine physicians in Decatur?
Dr. Jingo's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jingo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Decatur
Browse internal medicine physicians in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in GA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in GA
Which GA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology